GB202109362D0 - Vitamin K2 compositions - Google Patents
Vitamin K2 compositionsInfo
- Publication number
- GB202109362D0 GB202109362D0 GBGB2109362.0A GB202109362A GB202109362D0 GB 202109362 D0 GB202109362 D0 GB 202109362D0 GB 202109362 A GB202109362 A GB 202109362A GB 202109362 D0 GB202109362 D0 GB 202109362D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- vitamin
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2109362.0A GB2608393A (en) | 2021-06-29 | 2021-06-29 | Vitamin K2 compositions |
PCT/EP2022/067908 WO2023275149A1 (en) | 2021-06-29 | 2022-06-29 | Composition comprising vitamin k, vitamin d |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2109362.0A GB2608393A (en) | 2021-06-29 | 2021-06-29 | Vitamin K2 compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
GB202109362D0 true GB202109362D0 (en) | 2021-08-11 |
GB2608393A GB2608393A (en) | 2023-01-04 |
Family
ID=77179526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2109362.0A Pending GB2608393A (en) | 2021-06-29 | 2021-06-29 | Vitamin K2 compositions |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2608393A (en) |
WO (1) | WO2023275149A1 (en) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005065669A1 (en) * | 2003-12-19 | 2005-07-21 | Alcon, Inc. | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
US20130095204A1 (en) * | 2011-10-14 | 2013-04-18 | Zeina Jouni | Nutritional phytonutrient compositions |
WO2014028621A1 (en) * | 2012-08-14 | 2014-02-20 | Abbott Laboratories | Methods and compositions useful for improving bone and joint health |
CN103142640A (en) * | 2013-04-01 | 2013-06-12 | 李拖平 | Health care product containing vitamin K2 and having functions of preventing and treating brittle-bone disease |
PL3139904T3 (en) | 2014-05-05 | 2021-07-05 | Basf Se | Formulation of fat-soluble vitamin |
ITPD20140287A1 (en) * | 2014-10-30 | 2016-04-30 | Fusaro Maria | K-PHARMA |
US20180055802A1 (en) * | 2016-08-31 | 2018-03-01 | Nse Products, Inc. | Nutritional compositions and associated methods |
CN108125246A (en) * | 2018-01-24 | 2018-06-08 | 安徽顺和生物科技有限公司 | A kind of pregnant woman and wet nurse's nutrient supplement food formula |
CN110604308A (en) * | 2018-06-14 | 2019-12-24 | 深圳芙莱特营养与健康有限公司 | A nutritional composition with analgesic effect |
CN108936687A (en) * | 2018-08-08 | 2018-12-07 | 深圳极醇健康产业股份有限公司 | A kind of soft capsule and preparation method thereof of replenishing vitamins KD calcium |
CN113018264A (en) * | 2021-02-05 | 2021-06-25 | 澳汀斯(广州)生物医药科技有限公司 | Vitamin-encapsulated nano liposome preparation and preparation method thereof |
-
2021
- 2021-06-29 GB GB2109362.0A patent/GB2608393A/en active Pending
-
2022
- 2022-06-29 WO PCT/EP2022/067908 patent/WO2023275149A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
GB2608393A (en) | 2023-01-04 |
WO2023275149A1 (en) | 2023-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2585978B (en) | Therapeutic compositions | |
GB202013432D0 (en) | Compositions | |
GB202105461D0 (en) | Compositions | |
EP4175626A4 (en) | Novel pharmaceutical compositions | |
IL300090A (en) | Pharmaceutical compositions comprising venglustat | |
GB202015836D0 (en) | Compositions | |
GB202109362D0 (en) | Vitamin K2 compositions | |
IL312071A (en) | Pharmaceutical compositions | |
ZA202210764B (en) | Compositions | |
GB202208611D0 (en) | Compositions | |
GB202118081D0 (en) | Compositions | |
GB202117074D0 (en) | Compositions | |
GB202116861D0 (en) | Compositions | |
GB202116387D0 (en) | Compositions | |
GB202116386D0 (en) | Compositions | |
GB202116388D0 (en) | Compositions | |
GB202115617D0 (en) | Compositions | |
GB202019335D0 (en) | Pharmaceutical compositions | |
GB202114053D0 (en) | Compositions | |
GB202111897D0 (en) | Compositions | |
GB202109947D0 (en) | Compositions | |
GB202109945D0 (en) | Compositions | |
GB202109944D0 (en) | Compositions | |
GB202108656D0 (en) | Compositions | |
GB202013701D0 (en) | Pharmaceutical compositions |